Linda Lohr is a Portfolio Strategist for Pfizer. Linda has worked in small and large corporate environments in the pharmaceutical and petrochemical industries. Linda received a B.A. in Chemistry and Art History with a minor in Economics from Williams College. Linda received her Ph.D. in Physical Chemistry from Yale, where she designed solid state NMR instrumentation. Linda next post-doc’ed at Exxon-Mobil, where she developed polymerization catalysts, increasing polymer manufacturing productivity 4-fold.
At Otsuka Pharmaceuticals, she led the development of a new NMR spectrometer product line from engineering design through market launch. Linda later was recruited to join Pfizer as an analytical scientist. There she held positions of increasing responsibility in technology strategy, launching the division’s first NMR group, introducing solid state NMR to Pfizer, and launching the Structural Elucidation Group. Linda was awarded Pfizer’s Global Scientific Achievement Award for unifying the technology goals of multiple lines. As a Pharm Sci Team Leader, Linda won multiple awards for delivering the fastest CAN to first-in-patient in company history. Linda later joined Materials Science to lead solid form selection and solid state characterization.
Linda also orchestrated a panel of nation-wide experts spanning government and industry on healthcare reform and partnered with Public Affairs to impact science policy at state and federal levels. In her current role as Senior Director, Linda balances scientific strategy with business drivers to manage the pre-POC portfolio for Pharmaceutical Sciences. Throughout her career, Linda has held roles on both managerial and scientific ladders. She continues to be a mentor for others and is an active advocate for women’s issues and science policy. She is the author of numerous external scientific publications and presentations including four book chapters in the fields of materials science and analytical technologies.